BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790 | -17.2% | 20,934 | 0.0% | 0.78% | -5.8% |
| Q2 2023 | $954 | +374.6% | 20,934 | +432.1% | 0.83% | +292.0% |
| Q4 2022 | $201 | -99.9% | 3,934 | 0.0% | 0.21% | -10.5% |
| Q3 2022 | $212,000 | -17.5% | 3,934 | -1.9% | 0.24% | -10.9% |
| Q2 2022 | $257,000 | -17.4% | 4,009 | 0.0% | 0.27% | +4.3% |
| Q1 2022 | $311,000 | -9.6% | 4,009 | 0.0% | 0.26% | +9.9% |
| Q4 2021 | $344,000 | -2.0% | 4,009 | -8.2% | 0.23% | +6.9% |
| Q3 2021 | $351,000 | -0.3% | 4,367 | 0.0% | 0.22% | +8.5% |
| Q2 2021 | $352,000 | -4.3% | 4,367 | 0.0% | 0.20% | -6.1% |
| Q1 2021 | $368,000 | +5.1% | 4,367 | 0.0% | 0.21% | -7.0% |
| Q4 2020 | $350,000 | -0.3% | 4,367 | 0.0% | 0.23% | -28.9% |
| Q3 2020 | $351,000 | -1.1% | 4,367 | 0.0% | 0.32% | -24.9% |
| Q1 2020 | $355,000 | -3.5% | 4,367 | -0.8% | 0.43% | +30.0% |
| Q4 2019 | $368,000 | -34.3% | 4,400 | -31.2% | 0.33% | -31.7% |
| Q3 2019 | $560,000 | +6.9% | 6,400 | 0.0% | 0.48% | +31.6% |
| Q2 2019 | $524,000 | +0.8% | 6,400 | 0.0% | 0.37% | +7.3% |
| Q1 2019 | $520,000 | -6.0% | 6,400 | -23.8% | 0.34% | -20.3% |
| Q4 2018 | $553,000 | -14.7% | 8,400 | 0.0% | 0.43% | +10.3% |
| Q3 2018 | $648,000 | +4.5% | 8,400 | 0.0% | 0.39% | -12.4% |
| Q2 2018 | $620,000 | +171.9% | 8,400 | +140.0% | 0.44% | +116.6% |
| Q1 2018 | $228,000 | +0.9% | 3,500 | 0.0% | 0.20% | -5.5% |
| Q4 2017 | $226,000 | +2.7% | 3,500 | 0.0% | 0.22% | -5.7% |
| Q3 2017 | $220,000 | +3.8% | 3,500 | 0.0% | 0.23% | -2.1% |
| Q2 2017 | $212,000 | +5.0% | 3,500 | -10.3% | 0.24% | +13.0% |
| Q1 2017 | $202,000 | -52.7% | 3,900 | -37.5% | 0.21% | -41.9% |
| Q1 2015 | $427,000 | -75.4% | 6,240 | -73.7% | 0.36% | -76.0% |
| Q4 2014 | $1,739,000 | +4.8% | 23,723 | +2.6% | 1.49% | +6.3% |
| Q3 2014 | $1,660,000 | +0.2% | 23,123 | +0.9% | 1.40% | +20.3% |
| Q2 2014 | $1,657,000 | -2.1% | 22,923 | -0.3% | 1.17% | -1.8% |
| Q1 2014 | $1,692,000 | +6.5% | 22,990 | +0.7% | 1.19% | +10.7% |
| Q4 2013 | $1,589,000 | +5.9% | 22,840 | 0.0% | 1.07% | -0.6% |
| Q3 2013 | $1,500,000 | -5.2% | 22,840 | 0.0% | 1.08% | -14.2% |
| Q2 2013 | $1,582,000 | – | 22,840 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |